Deniger Drew 4
4 · Alaunos Therapeutics, Inc. · Filed Sep 19, 2022
Insider Transaction Report
Form 4
Deniger Drew
VP, Research and Development
Transactions
- Award
Employee Stock Option (right to buy)
2022-09-15+305,000→ 305,000 totalExercise: $2.11Exp: 2032-09-14→ Common Stock (305,000 underlying)
Footnotes (1)
- [F1]The options will vest in a series of sixteen equal quarterly installments measured from September 15, 2022, with the first vesting occurring on December 15, 2022, subject to the Reporting Person's continuous service through each such date.